Innovations of tomorrow
Rapid and reliable detection and quantification is of utmost importance for pharmaceutical industries. Our MuScan technology allows for the direct microbial detection and quantification from samples even within 1 hour. The dedicated Sieve-ID(TM) kits are validated according to USP and Ph.Eur 5.1.6 guidelines and the dedicated MuScan software is CFR21 part 11 compliant.
Microbial monitoring of end products and during production processes is of high importance to ensure best product quality and optimal production processes. Our MuScan technology and Sieve-ID kits are easy to use and provides rapid and direct microbial analysis of your products ranging from environmental samples to detergence samples.
Microbial analysis is required at each situation the presence of microbes impose a risk to affect product quality. Especially when time is limited and results are required immediately, our MuScan technology is indispensable. Detection and enumeration of microbial contaminants can be obtained even within 1 hour, compared to days using standard growth-based methods.
'As founder of Innosieve Diagnostics I am proud each time a customer is enthousiastic about our rapid and direct microbial method and is implementation our technology at their laboratories. This encourages us even more for further improvements and new innovations. Recently we have taken large steps to ensure high quality products that meet regulatory and customer demands. And that is our goal; Quality for Customers'
Ronald van Doorn
Being assigned from the early hours of Innosieve Diagnostics, I have seen the company grow. As R&D manager it is great to see new products being developed while diving into diagnostic hurdles of customers. Each time the team dives deeper, she finds new diagnostic solutions and possibilities to solve customer requests. And yet we have not reached the bottom. This is really challenging, keeping us all sharp and highly motivated. I am happy to be part of this as R&D manager.
Next Generation RMM - Direct Microbial Analysis
"Never seen a novel microbial method actually do precisely what it promises to do"Quote beverage customer
Automated scanning - Optical analysis at its edge
"People who look for the first time through a microscope say, 'Now I see this, and then I see that,' and even a skilled observer can be fooled. On these observations I have spent more time than many will believe, but I have done them with joy, and I have taken no notice of those who have said, 'Why take so much trouble,' and, 'What good is it?' "Quote Antoni van Leeuwenhoek. Dutch microbiologist, 1632-1723.
Responsive and CFR compliant - Full package
Besides CFR compliancy, the MuScan software can also be installed as so-called R&D package. This allows users in a research and development environment to use all advantages of the MuScan software, without the need for CFR-required limitations like double eye data confirmation. Testing and modifying image analysis protocols is allowed using the R&D MuScan software, providing custom protocol development for detection of your targets of interest.READ MORE
Lonza Pharma & Biotech and Innosieve Diagnostics announced today an exclusive distribution agreement for rapid bioburden testing technology. Under the agreement, Lonza will sell and distribute Innosieve’s MuScan™ Instrument, Sieve-ID® Total Viable Count Kit and associated software to the pharmaceutical, biotechnology and medical device manufacturing industries. [...]
After extensive studies the Sieve-ID Total Viable Count kit with MuScan analysis was found to be at least equal to the compendial method according to USP and Ph.Eur 5.1.6 for the direct detection and enumeration of viable microbes. The comparison of a growth-based method with a direct method has given Innosieve much insight in method validation approaches. [...]
We are proud to announce that the MuScan software meets 21 CFR part 11 compliancy. The software has a main focus on full digital processing and handling for optimal user friendliness. The software packages will soon be launched [...]
To align with the growth of Innosieve Diagnostics the contract with Kadans Vastgoed BV was extended. Innosieve Diagnostics has now doubled its space in housing to meet development and production needs.[...]
Innosieve Diagnostics has acquired the activities and intellectual properties of Lumibyte, subsidiary of Sioux. By acquisition of Lumibyte, Innosieve Diagnostics has now full ownership of all intellectual property of the MuScan device, including software. [...]
INNOSIEVE DIAGNOSTICS BV
To visit our R&D facilities in Wageningen, please find below the address information and the location on the map in Wageningen.
Nieuwe Kanaal 7A, 6709PA Wageningen, NL